Alexandra Amiel

423 total citations
17 papers, 141 citations indexed

About

Alexandra Amiel is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Neurology. According to data from OpenAlex, Alexandra Amiel has authored 17 papers receiving a total of 141 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Neurology. Recurrent topics in Alexandra Amiel's work include Brain Metastases and Treatment (6 papers), Glioma Diagnosis and Treatment (4 papers) and CNS Lymphoma Diagnosis and Treatment (3 papers). Alexandra Amiel is often cited by papers focused on Brain Metastases and Treatment (6 papers), Glioma Diagnosis and Treatment (4 papers) and CNS Lymphoma Diagnosis and Treatment (3 papers). Alexandra Amiel collaborates with scholars based in Israel, France and United States. Alexandra Amiel's co-authors include Xavier Declèves, Jean‐Michel Scherrmann, Jean‐Yves Delattre, Shlomit Yust‐Katz, Tali Siegal, Monica Sierra del Rio, Chantal Campello, Jérôme Barrière, Didier Frappaz and Marie‐Laure Tanguy and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Journal of the Neurological Sciences.

In The Last Decade

Alexandra Amiel

16 papers receiving 133 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexandra Amiel Israel 7 65 41 31 28 28 17 141
Nundia Louis United States 8 31 0.5× 44 1.1× 31 1.0× 149 5.3× 24 0.9× 16 267
Susan Eller United States 5 53 0.8× 57 1.4× 12 0.4× 32 1.1× 14 0.5× 7 164
Paula Codó Germany 5 31 0.5× 49 1.2× 50 1.6× 79 2.8× 18 0.6× 6 184
Rebecca Valentin United States 5 59 0.9× 71 1.7× 12 0.4× 105 3.8× 29 1.0× 12 248
Fatemeh Alikarami‬ Iran 9 30 0.5× 32 0.8× 24 0.8× 107 3.8× 7 0.3× 15 179
Naijie Liu China 7 38 0.6× 15 0.4× 88 2.8× 123 4.4× 19 0.7× 10 191
Joris Guyon France 9 56 0.9× 27 0.7× 33 1.1× 61 2.2× 3 0.1× 21 167
Joana Peixoto Portugal 7 26 0.4× 32 0.8× 90 2.9× 107 3.8× 5 0.2× 9 161
Salih Demir Germany 9 19 0.3× 52 1.3× 35 1.1× 120 4.3× 12 0.4× 14 217
Stefanie Krassnig Austria 7 14 0.2× 13 0.3× 37 1.2× 101 3.6× 8 0.3× 10 159

Countries citing papers authored by Alexandra Amiel

Since Specialization
Citations

This map shows the geographic impact of Alexandra Amiel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandra Amiel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandra Amiel more than expected).

Fields of papers citing papers by Alexandra Amiel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexandra Amiel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandra Amiel. The network helps show where Alexandra Amiel may publish in the future.

Co-authorship network of co-authors of Alexandra Amiel

This figure shows the co-authorship network connecting the top 25 collaborators of Alexandra Amiel. A scholar is included among the top collaborators of Alexandra Amiel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexandra Amiel. Alexandra Amiel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Dudnik, Elizabeth, I. Lavi, Ofer Rotem, et al.. (2025). The impact of brain MRI screening on stage IV NSCLC patients: A real world look at guidelines based care. Journal of the Neurological Sciences. 470. 123398–123398.
2.
Limon, Dror, Alexandra Amiel, Noa Gordon, et al.. (2024). A phase II, open-label, single-arm trial of pembrolizumab for recurrent meningioma and solitary fibrous tumor. Neuro-Oncology Advances. 6(1). vdae154–vdae154. 1 indexed citations
3.
Uziel, Orit, Andrew A. Kanner, Einat Beery, et al.. (2023). Is serum‐derived exosomal hTERT transcript a marker of oncogenic activity in primary brain tumors? An exploratory study. Cancer Medicine. 13(1). e6784–e6784. 6 indexed citations
4.
Bairey, Osnat, Alexandra Amiel, Shlomit Yust‐Katz, et al.. (2023). A phase 2 study of ibrutinib maintenance following first‐line high‐dose methotrexate‐based chemotherapy for elderly patients with primary central nervous system lymphoma. Cancer. 129(24). 3905–3914. 13 indexed citations
5.
Moore, Assaf, Shlomit Yust‐Katz, Noa Gordon, et al.. (2021). Bevacizumab for stereotactic radiosurgery-induced radiation necrosis in patients with non-small cell lung cancer treated with immune check-point inhibitors. Journal of the Neurological Sciences. 427. 117556–117556. 7 indexed citations
6.
Dudnik, Elizabeth, Ofer Rotem, Alona Zer, et al.. (2020). Tyrosine Kinase Inhibitors as a Treatment of Symptomatic CNS Metastases in Oncogene-Driven NSCLC. Journal of Oncology. 2020. 1–8. 3 indexed citations
7.
Yust‐Katz, Shlomit, Estela Derazne, Lior H. Katz, et al.. (2019). Echoes from the past- changing associations between brain tumors and ethnicity. Journal of the Neurological Sciences. 408. 116552–116552. 2 indexed citations
8.
Bairey, Osnat, Alexandra Amiel, Shlomit Yust‐Katz, Ronit Gurion, & T. Siegal. (2019). P05.04 Phase 2 open-label study of maintenance treatment with ibrutinib following first line methotrexate-based immuno-chemotherapy in elderly patients with primary CNS lymphoma (PCNSL). Neuro-Oncology. 21(Supplement_3). iii34–iii34. 3 indexed citations
9.
Yust‐Katz, Shlomit, T. Siegal, Alexandra Amiel, Estela Derazne, & J.D. Kark. (2018). P05.77 Echoes from the past- an historical cohort study of low dose radiation for tinea capitis and brain tumor incidence in Israel. Neuro-Oncology. 20(suppl_3). iii321–iii321. 1 indexed citations
10.
11.
Reyes-Botero, Germán, Jérôme Honnorat, Olivier Chinot, et al.. (2013). Temozolomide plus bevacizumab in elderly patients with newly diagnosed glioblastoma and poor performance status: An Anocef phase II trial.. Journal of Clinical Oncology. 31(15_suppl). 2020–2020. 13 indexed citations
12.
13.
Amiel, Alexandra. (2006). Integrating a Human Rights Perspective into the European Approach to Combating the Trafficking of Women for Sexual Exploitation. eYLS (Yale Law School). 12(1). 5. 9 indexed citations
14.
Declèves, Xavier, Alexandra Amiel, Jean‐Yves Delattre, & Jean‐Michel Scherrmann. (2006). Role of ABC Transporters in the Chemoresistance of Human Gliomas. Current Cancer Drug Targets. 6(5). 433–445. 58 indexed citations
15.
Nagler, Arnon, Michael Lishner, Alexandra Amiel, et al.. (1995). Potent antileukemic activity of the novel agents norsegoline and dibezine.. PubMed. 1(8). 823–9. 10 indexed citations
16.
Nagler, A., Michael Lishner, Alexandra Amiel, et al.. (1995). Potent antileukemic activity of the novel agents norsegoline and dibezine. Clin Cancer Res 1:823-829. 3 indexed citations
17.
Herpin, D, et al.. (1980). [Multi-cavity myxomas. Report of one case of bi-atrial myxoma and review of the literature (author's transl)].. PubMed. 29(7). 531–40. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nundia Louis Breakdown of academic impact, for papers by Susan Eller Breakdown of academic impact, for papers by Paula Codó Breakdown of academic impact, for papers by Rebecca Valentin Breakdown of academic impact, for papers by Fatemeh Alikarami‬ Breakdown of academic impact, for papers by Naijie Liu Breakdown of academic impact, for papers by Joris Guyon Breakdown of academic impact, for papers by Joana Peixoto Breakdown of academic impact, for papers by Salih Demir Breakdown of academic impact, for papers by Stefanie Krassnig
Rankless by CCL
2026